Skip to content

Clinical trials

Completed Major Depressive Disorder trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Status: Completed Country / region: South Korea Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20085
20093
20103
20115
20122
20131
20141
20151
20164
20172
20191
20202
20213
20224
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S5
Eli Lilly and Company3
Janssen Research & Development, LLC3
Pfizer3
Takeda3
Ewha Womans University2
Samsung Medical Center2
Sanofi2
Seoul National University Hospital2
Ajou University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder43
Depressive Disorder6
Mood Disorders4
Mental Disorders2
Anhedonia1
Anxiety Disorders1
Bipolar Disorder1
Dementia1
Depressive Disorder, Treatment-Resistant1
Dysthymic Disorder1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.